Borrower record · Q2 2026
Real Chemistry Intermediate III
As filed by 10 BDCs · period end 30 June 2026Filers label it: Pharmaceuticals (5), Services: Business (3)
10 lenders report $100.6m of Real Chemistry Intermediate III at Q2 2026, marked at 99.0 cents. First-Lien Senior Secured on all 17 positions whose seniority a filer disclosed.
- Filed fair value
- $100.6m
- 17 funded positions
- Reporting lenders
- 10
- across 27 filed positions
- Aggregate mark
- 99.0c
- covers 63% of positions with a filed cost
- Median spread
- 450bp
- over SOFR, 17 tranches
- Maturities to
- 2032
- earliest April 2032
- Periods on record
- 5
- first filed Q2 2025
How this total is counted
- Every figure above is the sum of 17 funded positions filed by 10 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
- 10 filed positions carry no positive fair value — unfunded or written off — and are outside every figure above.
Pricing as filed
17 floating tranches · SOFR450bp on all 17 floating tranches — every filer reports the same spread.
Capital structure
First-Lien Senior Secured, on all 17 positions whose seniority a filer disclosed.
Rate structure
Floating, on all 17 positions whose interest type a filer disclosed.
Maturity profile
all 17 funded positions dated5.8 years to maturity, weighted by fair value across the 17 dated positions.
Where the lenders disagree
10 filers disclosed a costLender marks on the same debt differ by up to 0.6c.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No sector. The filers' industry labels for Real Chemistry Intermediate III do not agree at NAICS sector level, so the ones two or more of them filed are shown above as filed.
- No period-by-period totals across the 5 periods on record. A single filer is separable somewhere in that history — at a period only one of them reported, or in the difference between two — so the series would give up that filer's position.
- No filed cost on 37% of positions, which the aggregate mark therefore excludes.
- No index floor filed on any tranche.
Sign up for free
Who holds it, and where they mark it.
10 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
10 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Antares Strategic Credit Fund II LLC | 0002065397 | 10-Q | 2026-06-30 | 2026-08-13 | 0001193125-26-349169 |
| Barings BDC, Inc. (BBDC) | 0001379785 | 10-Q | 2026-06-30 | 2026-08-05 | 0001379785-26-000030 |
| Barings Capital Investment Corp | 0001811972 | 10-Q | 2026-06-30 | 2026-08-05 | 0001811972-26-000018 |
| Barings Private Credit Corp | 0001859919 | 10-Q | 2026-06-30 | 2026-08-05 | 0001859919-26-000068 |
| LGAM Private Credit LLC | 0001983514 | 10-Q | 2026-06-30 | 2026-08-11 | 0001193125-26-344644 |
| Morgan Stanley Direct Lending Fund (MSDL) | 0001782524 | 10-Q | 2026-06-30 | 2026-08-06 | 0001193125-26-337915 |
| North Haven Private Income Fund A LLC | 0001973476 | 10-Q | 2026-06-30 | 2026-08-10 | 0001193125-26-342387 |
| North Haven Private Income Fund LLC | 0001851322 | 10-Q | 2026-06-30 | 2026-08-10 | 0001193125-26-342549 |
| Nuveen Churchill Direct Lending Corp. (NCDL) | 0001737924 | 10-Q | 2026-06-30 | 2026-08-06 | 0001737924-26-000084 |
| T Series BDC LLC | 0001885968 | 10-Q | 2026-06-30 | 2026-08-11 | 0001193125-26-344703 |
Related borrowers
Same lenders